OTC: HSTA
Hestia Insight Inc.CIK 0001813603 · SIC 8742 · Management Consulting Services
Unless the context otherwise requires, in this report, the terms “Hestia Insight”, “Company”, “HSTA”, “we”, or “our” refers to Hestia Insight Inc., a Nevada corporation. The Company’s principal office is located at 732 S. 6th Street #4762 Las Vegas, NV 89101. The Company’s telephone number is (516)… About this business →
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (PATH 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade HSTA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 20, 2026 (period ending May 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
| Description | Three months ended May 31, 2026 | Three months ended May 31, 2025 | Six months ended May 31, 2026 | Six months ended May 31, 2025 |
|---|---|---|---|---|
| REVENUE: | ||||
| Consulting revenue | 16,000 | – | 16,000 | – |
| Other Income | – | – | – | – |
| Total revenue | 16,000 | – | 16,000 | – |
| OPERATING EXPENSE: | ||||
| Selling, general and administrative expense [Note 5] | 537,074 | 122,237 | 576,401 | 232,907 |
| Total operating expense | 537,074 | 122,237 | 576,401 | 232,907 |
| OPERATING INCOME/(LOSS) | (521,074) | (122,237) | (560,401) | (232,907) |
| OTHER INCOME/(EXPENSE): | ||||
| Interest & dividend income | – | – | – | 75 |
| Gain (loss) on sale of capital assets | – | – | – | (14,203) |
| Realized Gain/(Loss) on Equity Investments | – | – | – | 435 |
| Unrealized Gain/(Loss) on Equity Investments | 42,414 | (127,917) | 88,195 | (387,417) |
| Interest expense | (3,463) | (2,307) | (6,766) | (4,080) |
| Bad debt expense | – | – | – | (6,660) |
| Total other income/(expense) | 38,951 | (130,224) | 81,429 | (411,850) |
| INCOME/(LOSS) BEFORE TAXES | (482,123) | (252,461) | (478,971) | (644,757) |
| Tax expense | – | – | – | – |
| NET INCOME/(LOSS) | (482,123) | (252,461) | (478,971) | (644,757) |
| Basic net income/(loss) per common share | (0.017) | (0.009) | (0.017) | (0.023) |
| Diluted net income/(loss) per common share | (0.017) | (0.009) | (0.017) | (0.023) |
| Average common shares outstanding Basic & Diluted | 27,939,260 | 27,939,260 | 27,939,260 | 27,939,260 |
Condensed Consolidated Balance Sheets (Unaudited)
| Description | May 31, 2026 | November 30, 2025 |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | 19,141 | 28,871 |
| Investments in equities | 454,453 | 366,260 |
| Total current assets | 473,594 | 395,131 |
| TOTAL ASSETS | 473,594 | 395,131 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| CURRENT LIABILITIES: | ||
| Accounts payable and accrued liabilities | 67,998 | 76,080 |
| Accrued interest, related party | 17,083 | 10,734 |
| Related party loan payable | 216,431 | 173,931 |
| Officer payable | 500,000 | – |
| Notes Payable, related party | 17,500 | 17,500 |
| Short-term loans from shareholders | 16,670 | – |
| Total current liabilities | 835,682 | 278,245 |
| TOTAL LIABILITIES | 835,682 | 278,245 |
| STOCKHOLDERS’ EQUITY (DEFICIT): | ||
| Common stock, par value $0.001 per share; 285,000,000 shares authorized; 27,939,260 and 27,939,260 shares issued and outstanding as of May 31, 2026, and November 30, 2025, respectively | 27,939 | 27,939 |
| Treasury Shares, 5,100,000 and 5,100,000 shares as of May 31, 2026, and November 30, 2025, respectively [Note 7 and Note 8] | 5,100 | 5,100 |
| Additional paid in capital | 1,141,613 | 1,141,613 |
| Accumulated deficit | (1,536,740) | (1,057,766) |
| Total stockholders’ equity (deficit) | (362,088) | 116,886 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | 473,594 | 395,131 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Description | Six months ended May 31, 2026 | Six months ended May 31, 2025 |
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net Income/(Loss) | (478,971) | (644,757) |
| Adjustments to reconcile net income/(loss) to operating cash flows: | ||
| Stock Based Compensation | – | 120,000 |
| Unrealized loss (gain) on investment equities | (88,195) | 387,116 |
| Gain/Loss sales of assets | – | 14,203 |
| Realized loss (gain) on investment equities | – | – |
| Depreciation expense | – | 700 |
| Bad Debt Expense | – | 6,660 |
| Changes in operating asset and liability account balances: | ||
| Accounts receivable and lease interest receivable | – | 8,000 |
| Credit card payable | – | (2,513) |
| Officer payable | 500,000 | – |
| Accounts payable and accrued interest payable | (1,734) | 45,915 |
| NET ADJUSTMENTS | 410,071 | 580,081 |
| NET CASH PROVIDED (USED) BY OPERATING ACTIVITIES | (68,900) | (64,676) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Proceeds (used in) purchase of investment equities | – | 7,845 |
| Proceeds provided by investment equities | – | – |
| NET CASH PROVIDED (USED) BY INVESTING ACTIVITIES | – | 7,845 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Proceeds provided by related party loan | 59,170 | 50,000 |
| NET CASH PROVIDED (USED) BY FINANCING ACTIVITIES | 59,170 | 50,000 |
| NET INCREASE (DECREASE) IN CASH | (9,730) | (6,831) |
| CASH BEGINNING OF PERIOD | 28,871 | 41,163 |
| CASH END OF PERIOD | 19,141 | 34,332 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗
About Hestia Insight Inc.
Source: Item 1 (Business) from the 10-K filed March 2, 2026. Description as filed by the company with the SEC.
ITEM 1. BUSINESS
General
Unless the context otherwise requires, in this report, the terms “Hestia Insight”, “Company”, “HSTA”, “we”, or “our” refers to Hestia Insight Inc., a Nevada corporation. The Company’s principal office is located at 732 S. 6th Street #4762 Las Vegas, NV 89101. The Company’s telephone number is (516) 212-0727. The Company reports its operations using a fiscal year ending November 30, and the operations reported on this Form 10-K are presented on a consolidated basis.
The Company files Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, registration statements and other items with the Securities and Exchange Commission (“SEC”). In this Annual Report on Form 10-K, the language “this fiscal year” or “current fiscal year” refers to the 12-month period ended November 30, 2025.
In addition, the public may read and copy any materials the Company’s files with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an internet site (www.sec.gov) that contains reports, proxy and information statements regarding issuers, like the Company, that file electronically with the SEC.
Overview
Hestia Insight Inc. (“Hestia”, “Hestia Insight”, or the “Company”) was incorporated in the State of Nevada on November 19, 2003, under the name Luxshmi Investments, Inc. (“Luxshmi Investments”), until the Company changed its name to Hestia Insight Inc. on March 27, 2019. On March 12, 2019, the Company filed a Certificate of Amendment to its Articles of Incorporation authorizing 300,000,000 shares of capital stock, comprised of 290,000,000 shares of common stock, par value $0.001 per share (the “Common Stock”) and 10,000,000 shares of preferred stock, par value $0.00001 per share (the “Preferred Stock”). On March 27, 2019, the Company filed a Certificate of Amendment to its Articles of Incorporation (i) effecting a name change from Luxshmi Investments, Inc. to Hestia Insight Inc., and (ii) effecting a 50-to-1 reverse stock split of the Company’s issued and outstanding shares of common stock (the “Reverse Stock Split”). The Reverse Stock Split did not impact the Company’s authorized shares of Common Stock or Preferred Stock, or its par value. On May 16, 2019, the Company entered into a Share Exchange Agreement with Hestia Investments Inc., a Wyoming corporation (“Hestia Investments”), to exchange, on a 1-for-1 basis, 27,614,200 shares of the Company’s Common Stock in exchange for 27,614,200 shares of Hestia Investments which were owned by 100% of the then-shareholders of Hestia Investments (the “Share Exchange Transaction”). As a result of the Share Exchange Transaction, Hestia Investments became a wholly owned subsidiary of the Company.
Read full description ↓
1
Now Hestia Insight Inc. (“Hestia Insight” and the “Company”) is an AI-powered capital markets advisory and business consulting firm specializing in comprehensive fundraising solutions for emerging growth companies. Through our proprietary artificial intelligence platform, we guide startups, small businesses, and growth-stage companies through the complete fundraising lifecycle - from pre-raise strategy and asset building to investor outreach and ongoing investor relations.
Our AI Enhanced Fundraising Services encompass four core areas: pre-raise strategy development including MVP creation and IP protection; comprehensive market research and financial modeling; investor materials preparation including pitch decks and due diligence support; and end-to-end investor outreach and relations management. We also provide fractional C-suite services, including Chief Strategy Officer and Chief Financial Officer support, to ensure our clients are transaction-ready and positioned for sustainable growth.
With a focus on transparency, expertise, and cutting-edge AI technology, Hestia Insight is committed to helping clients navigate the complexities of capital raising in today’s competitive marketplace. The Company maintains strategic focus on healthcare and biotech sectors through its two wholly owned operating subsidiaries, Hestia Investments Inc. (“Hestia Investments”) and HSTA Health Inc. (“HSTA Health”), while expanding its AI-powered advisory services across all industry verticals.
Hestia Insight is positioned to make strategic acquisitions of emerging growth companies with unique sciences and technologies and actively seeks licensing opportunities for exceptional products that complement our AI-powered service offerings. Through acquisition, licensing, joint ventures, and direct investment, we continue to build a comprehensive ecosystem of business development and capital markets solutions. For more information about Hestia Insight, please visit the Company’s website: www.hestiainsight.com
Business Model
Hestia Insight Inc. (“Hestia Insight” and the “Company”) is an AI-powered capital markets advisory and business consulting firm specializing in comprehensive fundraising solutions for emerging growth companies. Through our proprietary artificial intelligence platform, we guide startups, small businesses, and growth-stage companies through the complete fundraising lifecycle - from pre-raise strategy and asset building to investor outreach and ongoing investor relations.
Sales and Marketing
We seek to develop new business through relationships driven by our senior management, which have extensive contacts throughout the healthcare system. Our senior management is seeking opportunities for joint ventures, strategic relationships and acquisitions in the healthcare and biotech sectors.
Competitive Advantages
The Company focuses on small and micro-cap companies in the healthcare and biotech sectors with limited access to growth capital. We provide specialized consulting services to assist companies with their operations in the public markets. Our management team is experienced in risk management and exit planning. The Company’s competitive advantages include a global business network of healthcare, investment and financial professionals who are integrated into the technology licensing and commercialization departments of universities and institutions. Through our offered services and access to investment, we intend to accelerate the development and commercialization of the healthcare businesses that we engage with.
2
Intellectual Property
The Company owns no patents. We have not applied for or received patent protection in the US or any other country, and, as a result, there is a distinct risk that we will not be able to adequately protect our intellectual property rights in these countries. We own and control a variety of trade secrets, confidential information, trademarks, and other intellectual property rights that, in the aggregate, are of material importance to our business. We consider our trademarks, service marks, and other intellectual property to be proprietary, and rely on a combination of copyright, trademark, trade secret, non-disclosure, and contractual safeguards to protect our intellectual property rights.
Competition
In our current consulting business, we compete with a number of advisory firms offering similar service including consulting and strategy firms; market research, data, benchmarking, and forecasting providers; technology vendors and services firms; health care information technology firms; technology advisory firms; outsourcing firms; and specialized providers of advisory services. Other organizations, such as state and national trade associations, group purchasing organizations, non-profit think-tanks, and database companies, also may offer research, consulting, tools, and advisory services to health care organizations.
We believe that the principal competitive factors in our market include quality and timeliness of our services, strength and depth of relationships with our clients, ability to meet the changing needs of current and prospective clients, measurable returns on customer investment, and service and affordability.
As our business develops and we expand through joint ventures, acquisitions and strategic partnerships in the U.S., we will have competition with other direct service providers, emerging technologies and medical communication platforms. The Company will seek to maintain a competitive advantage through intellectual property, superior quality management and cutting-edge technology.
Government Regulation
The health care industry in the U.S. is highly regulated and subject to changing political, legislative, regulatory, and other influences. Further, the healthcare industry is currently undergoing rapid change. We are uncertain how, when or in what context these new changes will be adopted or implemented. These new regulations could create unexpected liabilities for us, could cause us or our members to incur additional costs and could restrict our or our clients’ operations. Many of the laws are complex and their application to us, our clients, or the specific services and relationships we have are not always clear. Our failure to anticipate accurately the application of these laws and regulations, or our other failure to comply, could create liability for us, result in adverse publicity, and otherwise negatively affect our business.
Employees
The Company has three employees. We otherwise rely on the services of independent contractors.
Our Offices
Our principal executive office is located at
732 S. 6th Street #4762 Las Vegas, NV 89101.
Our Website
www.HestiaInsight.com
3
Legal Proceedings
From time to time, we are subject to ordinary routine litigation incidental to our normal business operations. We are not currently a party to, and our property is not subject to, any material legal proceedings.
Reports to Security Holders
We intend to furnish our shareholders annual reports containing financial statements audited by our independent registered public accounting firm and to make available quarterly reports containing unaudited financial statements for each of the first three quarters of each year. We file Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K with the SEC in order to meet our timely and continuous disclosure requirements. We may also file additional documents with the SEC if they become necessary in the course of our company’s operations.
The public may read and copy any materials that we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is www.sec.gov.
4